Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
| INBS Stock | USD 1.48 0.01 0.68% |
Slightly above 51% of Intelligent Bio's investor base is interested to short. The analysis of overall sentiment of trading Intelligent Bio Solutions stock suggests that many investors are impartial at this time. Intelligent Bio's investing sentiment can be driven by a variety of factors including economic data, Intelligent Bio's earnings reports, geopolitical events, and overall market trends.
Intelligent | Build AI portfolio with Intelligent Stock |
INBS wins major London transport contract, expanding use of its fingerprint drug testing solution ahead of planned U.S. market entry in 2025....
Read at globenewswire.com
 |
Intelligent Bio Fundamental Analysis
We analyze Intelligent Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intelligent Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intelligent Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Intelligent Bio is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Intelligent Bio Solutions Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Intelligent Bio stock to make a market-neutral strategy. Peer analysis of Intelligent Bio could also be used in its relative valuation, which is a method of valuing Intelligent Bio by comparing valuation metrics with similar companies.
Peers
Intelligent Bio Related Equities
| TWI | Titan International | 7.62 | ||||
| DIT | AMCON Distributing | 6.42 | ||||
| IIIN | Insteel Industries | 4.64 | ||||
| BOF | BranchOut Food | 2.87 | ||||
| GGB | Gerdau SA | 2.76 | ||||
| BLSFY | BlueScope Steel | 1.36 | ||||
| RCLFF | RCL Foods | 0.00 | ||||
| SECVY | Seche Environnement | 0.00 |
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.